BPA for phospholine iodide
Active Awarded Last action
- Contract number
- 36E79724A0013
- Awardee
-
Fera Pharmaceuticals, LLC UEI ZNE7HKFJNMB8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 84% complete
- IDV ceiling
- $255,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Fera Pharmaceuticals, LLC, a woman-owned small business specializing in eye health pharmaceuticals, was awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs National Acquisition Center for the supply of Phospholine Iodide, a pharmaceutical drug used in ophthalmologic treatment. The contract was awarded on April 17, 2024, with a ceiling value of $255,000 and an ultimate completion date of April 16, 2027. This BPA represents the exercise of Option Year 2 under the original agreement (36E79724A0013) and operates under the Federal Supply Schedule Pharmaceuticals and Drugs (FSS-61-IB) master schedule. No set-aside was utilized for this award, and the contract provides the VA with the ability to efficiently procure Phospholine Iodide in compliance with federal acquisition regulations.
This indefinite delivery vehicle enables the VA to procure pharmaceutical supplies from Fera Pharmaceuticals on an as-needed basis up to the established ceiling amount, eliminating the need for individual competitive procurements for each requirement. The Phospholine Iodide supplied under this BPA supports ophthalmic treatment protocols within the VA's Veterans Health Administration network, particularly serving veterans with eye health conditions that may represent niche or orphan conditions. By leveraging the Blanket Purchase Agreement structure, the VA achieves procurement efficiency while ensuring access to specialized pharmaceutical products critical for veterans' healthcare delivery.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79724A0013?
36E79724A0013 was awarded to Fera Pharmaceuticals, LLC by National Acquisition Center (Headquarters) on April 17, 2024.
How much is contract 36E79724A0013 worth?
36E79724A0013's own ceiling is $255,000.
Who can order from contract 36E79724A0013?
36E79724A0013 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79724A0013 under another contract?
Yes. 36E79724A0013 is a blanket purchase agreement under 36F79721D0142, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79724A0013 competed?
The extent of competition for 36E79724A0013 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV